TSC1 — Tuberous Sclerosis Complex 1
Introduction
Tsc1 — Tuberous Sclerosis Complex 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
Tuberous Sclerosis Complex 1 (TSC1) encodes the protein hamartin, a crucial tumor suppressor protein that plays essential roles in cell growth, proliferation, and synaptic function. Mutations in TSC1 cause tuberous sclerosis complex, a genetic disorder characterized by benign tumors (hamartomas) throughout the body, including the brain, where they can cause seizures, developmental delays, and increased risk of neurodegenerative processes. [@tee2002]
<div class="infobox infobox-gene"> [@ehninger2008]
| Property | Value | [@osborne1991]
|----------|-------| [@citrigno2020]
| Gene Symbol | TSC1 | [@franz2013]
| Full Name | Tuberous Sclerosis Complex 1 | [@nie2010]
| Chromosomal Location | 9q34 | [@kwiatkowski2002]
| NCBI Gene ID | 7248 |
| Ensembl ID | ENSG00000115159 |
| OMIM ID | 191100 |
| UniProt ID | Q9UPZ6 |
| Protein Name | Hamartin |
| Molecular Weight | ~130 kDa |
</div>
Normal Function
Hamartin Protein Structure and Localization
Hamartin is a 1,164 amino acid protein primarily localized to the cytoplasm and plasma membrane. It contains several functional domains including a hamartin elbow domain (HED), a transmembrane region, and a conserved tuberous sclerosis complex domain (TSC-TBD)<sup>[1]</sup>. Hamartin forms a heterodimer with TSC2 (tuberin), which is essential for their tumor suppressor function.
Role in mTOR Signaling
The TSC1/TSC2 complex serves as a critical regulator of the [mTOR](/entities/mtor) (mechanistic target of rapamycin) signaling pathway, a central regulator of cell growth and metabolism. The TSC1-TSC2 complex acts as a GTPase-activating protein (GAP) toward Rheb (Ras homolog enriched in brain), inhibiting mTORC1 activity when cellular energy levels are low or growth factors are scarce<sup>[2]</sup>. When TSC1 is functional, it helps maintain [mTOR](/mechanisms/mtor-signaling-pathway) signaling homeostasis, ensuring proper protein synthesis, [autophagy](/entities/autophagy), and cell growth.
Synaptic Function
Beyond its role in cell growth, TSC1 is expressed in [neurons](/entities/neurons) and plays important roles in synaptic plasticity, dendritic spine morphology, and neuronal connectivity. TSC1 haploinsufficiency affects synaptic function and can lead to altered [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and learning deficits in mouse models<sup>[3]</sup>.
Disease Associations
Tuberous Sclerosis Complex (TSC)
Tuberous sclerosis complex is an autosomal dominant genetic disorder caused by heterozygous pathogenic variants in either TSC1 or TSC2. It affects approximately 1 in 6,000-10,000 live births and has a birth incidence of about 1 in 5,800<sup>[4]</sup>. The disease is characterized by:
- Cortical tubers: Benign hamartomas in the cerebral [cortex](/brain-regions/cortex)
- Subependymal giant cell astrocytomas (SEGAs): Tumors in the ventricles
- Facial angiofibromas: Adenoma sebaceum
- Hypomelanotic macules: Ash-leaf spots
- Shagreen patches: Connective tissue nevi
Neurological Manifestations
- Epilepsy: Occurs in 70-90% of TSC patients, often beginning in infancy
- Intellectual disability: Present in approximately 50% of cases
- Autism spectrum disorder: Affects 20-50% of individuals
- Tuberous sclerosis-associated neuropsychiatric disorders (TAND)
Neurodegenerative Implications
Recent research has revealed connections between TSC1 dysfunction and neurodegenerative processes:
- mTOR hyperactivation: Constitutive mTOR activation due to TSC1/TSC2 loss leads to impaired autophagy and accumulation of damaged proteins and organelles<sup>[5]</sup>
- Epilepsy-induced neurodegeneration: Chronic seizures in TSC can lead to progressive cognitive decline
- Protein aggregation: Dysregulated mTOR signaling can contribute to abnormal protein aggregation similar to that seen in Alzheimer's and other neurodegenerative diseases
Therapeutic Implications
The mTOR inhibitor everolimus has shown efficacy in treating TSC-related tumors and epilepsy, highlighting the importance of mTOR pathway modulation in this disorder<sup>[6]</sup>. Rapamycin and its analogs are now standard treatments for SEGAs and renal angiomyolipomas in TSC patients.
Expression Patterns
Hamartin is expressed in most human tissues, with high expression in:
- Brain (cerebral cortex, cerebellum, hippocampus)
- Heart
- Kidney
- Lung
- Skin
In the brain, TSC1 is expressed in neurons, [astrocytes](/entities/astrocytes), and oligodendrocytes, with particular importance in synaptic compartments.
Background
The study of Tsc1 — Tuberous Sclerosis Complex 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
- [Allen Human Brain Atlas: TSC1](https://human.brain-map.org/microarray/search/show?search_term=TSC1) — Gene expression data across human brain regions
- [Allen Mouse Brain Atlas: TSC1](https://mouse.brain-map.org/microarray/search/show?search_term=TSC1) — Gene expression data in mouse brain
- [BrainSpan Atlas of the Developing Human Brain: TSC1](https://www.brainspan.org/search?search_term=TSC1) — Developmental expression data
See Also
- [Tuberous Sclerosis Complex (Disease Page - if exists)](/tuberous-sclerosis-complex-(disease-page---if-exists))
- [mTOR Signaling Pathway](/mechanisms/mtor-signaling-pathway)
- TSC2 - Tuberin
- Epilepsy Mechanisms
- [Autophagy in Neurodegeneration](/mechanisms/autophagy-neurodegeneration)
External Links
- [NCBI Gene: TSC1](https://www.ncbi.nlm.nih.gov/gene/7248)
- [UniProt: Q9UPZ6](https://www.uniprot.org/uniprot/Q9UPZ6)
- [OMIM: 191100](https://www.omim.org/entry/191100)
- [Tuberous Sclerosis Alliance](https://www.tsalliance.org/)
- [Ensembl: ENSG00000115159](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000115159)
References
[van Slegtenhorst M, et al, (1997) (1997)](https://pubmed.ncbi.nlm.nih.gov/9242607/)
[Tee AR, et al, (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12007410/)
[Ehninger D, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18568033/)
[Osborne JP, et al, (1991) (1991)](https://pubmed.ncbi.nlm.nih.gov/2037612/)
[Citrigno L, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/33171677/)
[Franz DN, et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23810380/)
[Nie D, et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20383140/)
[Kwiatkowski DJ, et al, (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12086760/)Pathway Diagram
The following diagram shows the key molecular relationships involving TSC1 — Tuberous Sclerosis Complex 1 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)